Medoclav (Amoxicillin, Clavulanic Acid)

• Medoclav, a beta‑lactam antibacterial, is indicated for infections caused by susceptible bacteria in various organ systems.
• Community‑acquired pneumonia: effective in achieving clinical cure and microbiological eradication in adult patients.
• Skin and soft tissue infections: reduces infection severity and promotes healing of cellulitis, abscesses and wound infections.
• Intra‑abdominal infections: facilitates resolution of peritonitis and complicated intra‑abdominal sepsis when used with appropriate surgical source control.
• Urinary tract infections: contributes to symptomatic relief and bacterial clearance in acute uncomplicated UTIs.
• Sinusitis: improves clinical outcomes and reduces bacterial load in acute bacterial sinus infections.

• Amoxicillin inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, preventing peptidoglycan cross‑linking. Clavulanic acid, a β‑lactamase inhibitor, binds irreversibly to β‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from enzymatic degradation and extending its antimicrobial spectrum against β‑lactamase‑producing organisms. The combined effect results in bactericidal activity against a broad range of Gram‑positive and Gram‑negative pathogens, including Haemophilus influenzae, Streptococcus pneumoniae and Escherichia coli.

Adverse reactions to Medoclav may vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools, sometimes watery.
• Rash: mild skin erythema or itching.
• Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

• Anaphylaxis: severe, potentially life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder.
• Clostridioides difficile‑associated colitis: severe intestinal inflammation due to bacterial overgrowth.

• Before prescribing Medoclav, clinicians should consider several precautionary measures to ensure safe use.
• Renal impairment: adjust dose or monitor renal function in patients with reduced kidney clearance.
• Hepatic dysfunction: use with caution in patients with liver disease and monitor liver enzymes.
• History of hypersensitivity: avoid in individuals with known allergy to penicillins or β‑lactamase inhibitors.
• Concomitant anticoagulants: monitor INR or clotting parameters as the drug may enhance anticoagulant effects.
• Pregnancy and lactation: assess risk‑benefit; limited data, use only if clearly needed.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Medoclav can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Probenecid: may increase amoxicillin plasma concentrations, raising toxicity risk.
• Allopurinol: combined use can heighten risk of rash, including severe cutaneous reactions.

Moderate Interactions (Monitor Closely)

• Oral anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring.
• Oral contraceptives: antibiotics may reduce contraceptive effectiveness; advise additional contraception.
• Methotrexate: reduced renal clearance may increase methotrexate toxicity.
• Diuretics (e.g., furosemide): may increase risk of electrolyte disturbances.